Ignite Creation Date:
2025-12-24 @ 3:54 PM
Ignite Modification Date:
2026-01-06 @ 7:14 AM
Study NCT ID:
NCT00336492
Status:
COMPLETED
Last Update Posted:
2013-07-30
First Post:
2006-06-09
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of the Safety and Efficacy of Infliximab(REMICADE ) in Pediatric Patients With Moderately to SeverelyActive Ulcerative Colitis
Sponsor:
Centocor, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-09
Start Date Type:
None
Primary Completion Date:
2009-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-04
Completion Date Type:
ACTUAL
First Submit Date:
2006-06-09
First Submit QC Date:
None
Study First Post Date:
2006-06-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-07-14
Results First Submit QC Date:
None
Results First Post Date:
2011-08-10
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2009-12-18
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2013-07-24
Last Update Post Date:
2013-07-30
Last Update Post Date Type:
ESTIMATED